Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital

Benzinga
2025.10.15 11:06

同意回購 ADAR1 Capital Management 和 Pontifax Venture Capital 持有的所有股份，計劃開始要約回購最多 1.94 億美元的額外股份

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.